1795 related articles for article (PubMed ID: 21550068)
41. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Sato DK; Nakashima I; Takahashi T; Misu T; Waters P; Kuroda H; Nishiyama S; Suzuki C; Takai Y; Fujihara K; Itoyama Y; Aoki M
Neurology; 2013 Jun; 80(24):2210-6. PubMed ID: 23677744
[TBL] [Abstract][Full Text] [Related]
42. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
43. [NMO spectrum disorders and anti AQP4 antibody].
Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
[TBL] [Abstract][Full Text] [Related]
44. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
Yang Y; Wu WP; Huang DH; Wu L
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
[TBL] [Abstract][Full Text] [Related]
45. [Anti-aquaporin 4 antibody in Japanese multiple sclerosis with long spinal cord lesions].
Tanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):852-4. PubMed ID: 18210816
[TBL] [Abstract][Full Text] [Related]
46. Immunopathogenesis of neuromyelitis optica.
Levy M; Wildemann B; Jarius S; Orellano B; Sasidharan S; Weber MS; Stuve O
Adv Immunol; 2014; 121():213-42. PubMed ID: 24388217
[TBL] [Abstract][Full Text] [Related]
47. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
48. Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
Jarius S; Franciotta D; Paul F; Bergamaschi R; Rommer PS; Ruprecht K; Ringelstein M; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2012 Sep; 320(1-2):32-7. PubMed ID: 22705047
[TBL] [Abstract][Full Text] [Related]
49. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.
Jarius S; Frederikson J; Waters P; Paul F; Akman-Demir G; Marignier R; Franciotta D; Ruprecht K; Kuenz B; Rommer P; Kristoferitsch W; Wildemann B; Vincent A
J Neurol Sci; 2010 Nov; 298(1-2):158-62. PubMed ID: 20850793
[TBL] [Abstract][Full Text] [Related]
50. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
[TBL] [Abstract][Full Text] [Related]
51. Neuromyelitis optica and asian phenotype of multiple sclerosis.
Kira J
Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121
[TBL] [Abstract][Full Text] [Related]
52. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
[TBL] [Abstract][Full Text] [Related]
53. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.
Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC
J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609
[TBL] [Abstract][Full Text] [Related]
54. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
55. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
Juryńczyk M; Craner M; Palace J
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):20-5. PubMed ID: 25248365
[TBL] [Abstract][Full Text] [Related]
56. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
[TBL] [Abstract][Full Text] [Related]
57. [New insights into the pathogenesis of neuromyelitis optica].
Misu T; Takahashi T; Nishiyama S; Takano R; Nakashima I; Fujihara K; Itoyama Y
Brain Nerve; 2010 Sep; 62(9):921-31. PubMed ID: 20844303
[TBL] [Abstract][Full Text] [Related]
58. [Anti-aquaporin 4-antibody detection system].
Tanaka K
Nihon Rinsho; 2008 Jun; 66(6):1093-7. PubMed ID: 18540353
[TBL] [Abstract][Full Text] [Related]
59. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
60. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
